Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009553 |
---|---|
Receipt number | R000011054 |
Scientific Title | Comparison of anti-inflammatory effects of rivaroxaban versus dabigatran in patients with non-valvular atrial fibrillation (RIVAL-AF study) -Multicenter randomized study- |
Date of disclosure of the study information | 2012/12/14 |
Last modified on | 2019/01/04 16:51:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/12/14 20:36:56 | ||
2 | Update | 2013/07/24 10:04:47 | Public title Public title Acronym Acronym |
|
3 | Update | 2013/07/24 10:41:34 | Randomization Randomization unit Stratification Dynamic allocation Institution consideration Blocking Concealment Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
4 | Update | 2013/07/24 10:52:03 | Recruitment status Date of protocol fixation Anticipated trial start date Last follow-up date |
|
5 | Update | 2013/07/24 11:01:00 | Public title Acronym |
|
6 | Update | 2013/12/18 14:14:51 | Email Institutions |
|
7 | Update | 2015/01/04 11:56:58 | Target sample size |
|
8 | Update | 2015/01/04 12:00:30 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
9 | Update | 2015/01/04 12:05:46 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
10 | Update | 2015/05/31 13:50:01 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
11 | Update | 2015/05/31 14:07:27 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
12 | Update | 2016/06/29 13:20:51 | Date analysis concluded |
|
13 | Update | 2017/06/19 20:51:35 | Name of primary person or sponsor Organization |
|
14 | Update | 2019/01/04 16:51:14 | Recruitment status Date analysis concluded Publication of results Results Results |